1. ScholarBank@NUS

Alan Prem Kumar

rp02898

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Alan Prem Kumar
Variants
Kumar, A.P.
Kumar, A.
Prem Kumar, A.
Kumar, Alan Prem Rem
 
Main Affiliation
 
Faculty
 
Email
apkumar@nus.edu.sg
 
Other emails
 

Publications

Refined By:
Department:  DEAN'S OFFICE (MEDICINE)
Subject:  Apoptosis

Results 1-15 of 15 (Search time: 0.006 seconds).

Issue DateTitleAuthor(s)
12013An anthraquinone derivative, emodin sensitizes hepatocellular carcinoma cells to TRAIL induced apoptosis through the induction of death receptors and downregulation of cell survival proteinsSubramaniam, A.; Loo, S.Y.; Rajendran, P.; Manu, K.A. ; Perumal, E.; Li, F.; Shanmugam, M.K. ; Siveen, K.S.; Park, J.-I.; Ahn, K.S.; Hui, K.M.; Kumar, A.P. ; Sethi, G.
21-Sep-2011Anticancer activity of thymoquinone in breast cancer cells: Possible involvement of PPAR-γ pathwayWoo, C.C.; Loo, S.Y.; Gee, V.; Yap, C.W. ; Sethi, G.; Kumar, A.P. ; Benny Tan, K.H.
3Oct-2011Celastrol inhibits tumor cell proliferation and promotes apoptosis through the activation of c-Jun N-terminal kinase and suppression of PI3 K/Akt signaling pathwaysKannaiyan, R.; Manu, K.A. ; Chen, L.; Li, F.; Rajendran, P.; Subramaniam, A.; Lam, P.; Kumar, A.P. ; Sethi, G.
4Apr-2013Deciphering the signaling networks underlying simvastatin-induced apoptosis in human cancer cells: Evidence for non-canonical activation of RhoA and Rac1 GTPasesZhu, Y.; Casey, P.J. ; Kumar, A.P. ; Pervaiz, S.
52019Inhibition of TFF3 enhances sensitivity—and overcomes acquired resistance—to doxorubicin in estrogen receptor-positive mammary carcinomaPoh, H.M.; Chiou, Y.S.; Chong, Q.Y. ; Chen, R.-M. ; Rangappa, K.S.; Ma, L.; Zhu, T.; Kumar, A.P. ; Pandey, V.; Basappa, Department of Studies in Organic Chemistry, University of Mysore, Mysore, 570005, India.; Lee, S.-C. ; Lobie, P.E. 
615-Nov-2012Key cell signaling pathways modulated by zerumbone: Role in the prevention and treatment of cancerPrasannan, R.; Kalesh, K.A.; Shanmugam, M.K. ; Nachiyappan, A.; Ramachandran, L.; Nguyen, A.H.; Kumar, A.P. ; Lakshmanan, M.; Ahn, K.S.; Sethi, G.
72020Polychemotherapy with curcumin and doxorubicin via biological nanoplatforms: Enhancing antitumor activityAshrafizadeh, M.; Zarrabi, A.; Hashemi, F.; Zabolian, A.; Saleki, H.; Bagherian, M.; Azami, N.; Bejandi, A.K.; Hushmandi, K.; Ang, H.L.; Makvandi, P.; Khan, H.; Kumar, A.P. 
8Jan-2013Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinomaSubramaniam, A.; Shanmugam, M.K. ; Perumal, E.; Li, F.; Nachiyappan, A.; Dai, X.; Swamy, S.N.; Ahn, K.S.; Kumar, A.P. ; Tan, B.K.H.; Hui, K.M.; Sethi, G.
94-Mar-2021Review micrornas as modulators of oral tumorigenesis—a focused reviewRishabh, Kumar; Khadilkar, Soham; Kumar, Aviral; Kalra, Ishu; Kumar, Alan Prem ; Kunnumakkara, Ajaikumar B.
102013Role of NF-κB in tumorigenesisShanmugam, M.K. ; Kumar, A.P. ; Tan, B.K.H.; Sethi, G.
112014Simvastatin sensitizes human gastric cancer xenograft in nude mice to capecitabine by suppressing nuclear factor-kappa B-regulated gene productsManu, K.A.; Shanmugam, M.K. ; Li, F.; Chen, L.; Siveen, K.S.; Ahn, K.S.; Kumar, A.P. ; Sethi, G.
121-Dec-2013Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancerShrimali, D.; Shanmugam, M.K. ; Kumar, A.P. ; Zhang, J.; Tan, B.K.H.; Ahn, K.S.; Sethi, G.
1328-Jul-2012Targeted inhibition of tumor proliferation, survival, and metastasis by pentacyclic triterpenoids: Potential role in prevention and therapy of cancerShanmugam, M.K. ; Nguyen, A.H.; Kumar, A.P. ; Tan, B.K.H.; Sethi, G.
1415-Feb-2012Thymoquinone: Potential cure for inflammatory disorders and cancerWoo, C.C.; Kumar, A.P. ; Sethi, G.; Tan, K.H.B.
151-Jun-2013Ursolic acid in cancer prevention and treatment: Molecular targets, pharmacokinetics and clinical studiesShanmugam, M.K. ; Dai, X.; Kumar, A.P. ; Tan, B.K.H.; Sethi, G.; Bishayee, A.